Cancer modeling in colorectal organoids reveals intrinsic differences between oncogenic RAS and BRAF variants
J. B. Post, N. Hami, J. Lohuis, M. van de Ven, R. de Korte-Grimmerink, C. S. Stangl, E. Stelloo, I. Verlaan, J. van Rheenen, H. J. G. Snippert
This study uses CRISPR to generate CRC organoids with different RAS pathway mutations, revealing distinct drug responses and growth patterns.
bioRxiv · Nov 29, 2019 · PreprintCancer Biology